Thus, our data suggest the additional administration of the DNA construct encoding NKG2D-Fc-IL2 is able to enhance the therapeutic anti-tumor effect first generated by the gene gun-administered CRT-E7 DNA vaccine. The gene discussed is KLRK1; the disease is neoplasm.